Legal
-
Call for government intervention in radioligand stoush
- 26 Feb 2025
In response to Novartis’ legal action against local suppliers, this industry body says the Government must ‘act swiftly to ensure patients can access treatment’.
Read more -
Sun set to challenge $50M PBS market
- 10 Feb 2025
Lundbeck’s patent extension found to be invalid just as the TGA approves a newer long-acting version of its leading injectable.
Read more -
Medtronic to pay $22m fine for ARTG breach
- 20 Sep 2024
While declared ‘the largest ever’ penalty imposed for contravening the TG Act, Medtronic takes its medicine – and it could have been far worse.
Read more -
BMS clawback case sparks up
- 28 Aug 2024
An appeal in the Sanofi clawback case has coincided with the reappearance of the BMS/Otsuka clawback case after a long out-of-court sojourn.
Read more -
Pfizer overturns TGA rejection
- 16 Aug 2024
It took 3.5 years and an external review but Pfizer was eventually successful in registering its oral therapy with most of the indication it wanted.
Read more -
Sanofi ‘clawback’ case back in court
- 14 Aug 2024
Seventeen years after this patent battle hit the courts, it is about to enter another round – and this time in the highest court in the land.
Read more -
TGA cracks down on Ozempic ads
- 15 Jul 2024
Regulator issues more than $300,000 in fines as it tries to rein in unlawful advertising of unapproved medicines for weight loss.
Read more -
GP to fight on against Pfizer, Moderna
- 04 Mar 2024
‘I have asked my lawyers to appeal the decision. I hope that they will agree with me that the decision cannot stand,’ says Aussie doctor.
Read more




